247 related articles for article (PubMed ID: 35089495)
1. MiR-24-3p Attenuates Doxorubicin-induced Cardiotoxicity via the Nrf2 Pathway in Mice.
Fan D; Chen HB; Leng Y; Yang SJ
Curr Med Sci; 2022 Feb; 42(1):48-55. PubMed ID: 35089495
[TBL] [Abstract][Full Text] [Related]
2. miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice.
Hu X; Liu H; Wang Z; Hu Z; Li L
Oxid Med Cell Longev; 2019; 2019():1512326. PubMed ID: 31781322
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2.
Zhao L; Qi Y; Xu L; Tao X; Han X; Yin L; Peng J
Redox Biol; 2018 May; 15():284-296. PubMed ID: 29304479
[TBL] [Abstract][Full Text] [Related]
4. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
[TBL] [Abstract][Full Text] [Related]
5. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Zhang WB; Lai X; Guo XF
Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
[TBL] [Abstract][Full Text] [Related]
6. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
7. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
9. Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice.
Tuo H; Li W; Zhao W; Zhao J; Li D; Jin L
Sci Rep; 2024 Jan; 14(1):924. PubMed ID: 38195835
[TBL] [Abstract][Full Text] [Related]
10. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1.
Zhao X; Jin Y; Li L; Xu L; Tang Z; Qi Y; Yin L; Peng J
Pharmacol Res; 2019 Aug; 146():104276. PubMed ID: 31112750
[TBL] [Abstract][Full Text] [Related]
12. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
[TBL] [Abstract][Full Text] [Related]
13. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
15. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.
Lin H; Zhang J; Ni T; Lin N; Meng L; Gao F; Luo H; Liu X; Chi J; Guo H
J Cell Mol Med; 2019 Sep; 23(9):6034-6047. PubMed ID: 31225944
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-495-3p diminishes doxorubicin-induced cardiotoxicity through activating AKT.
Meng J; Xu C
J Cell Mol Med; 2022 Apr; 26(7):2076-2088. PubMed ID: 35152537
[TBL] [Abstract][Full Text] [Related]
17. MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway.
Fu Q; Pan H; Tang Y; Rong J; Zheng Z
Cardiovasc Toxicol; 2021 Apr; 21(4):302-313. PubMed ID: 33638775
[TBL] [Abstract][Full Text] [Related]
18. Exosomal LncRNA-NEAT1 derived from MIF-treated mesenchymal stem cells protected against doxorubicin-induced cardiac senescence through sponging miR-221-3p.
Zhuang L; Xia W; Chen D; Ye Y; Hu T; Li S; Hou M
J Nanobiotechnology; 2020 Oct; 18(1):157. PubMed ID: 33129330
[TBL] [Abstract][Full Text] [Related]
19. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane protection against the development of doxorubicin-induced chronic heart failure is associated with Nrf2 Upregulation.
Bai Y; Chen Q; Sun YP; Wang X; Lv L; Zhang LP; Liu JS; Zhao S; Wang XL
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28636290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
